FY2025 · ended Dec 31, 2025 · Revenue $70.88M, +10.9% YoY · Filed Feb 12, 2026
AVITA Medical, Inc. (RCEL) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $70.9 million and a net loss of $48.6 million. Free cash flow was -$32.2 million. As of Jun 30, 2026 it held $11.1 million in cash and investments and $48.5 million in total debt.
Revenue (TTM)
$74.88M
+1.0% vs year-ago TTM
Net income (TTM)
$-43.08M
+16.5% vs year-ago TTM
Operating cash flow (TTM)
$-24.23M
+32.3% vs year-ago TTM
Free cash flow (TTM)
$-24.62M
+41.3% vs year-ago TTM
EPS (TTM)
$-1.44
+26.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
30.63M
+16.2% vs prior year
Net cash
$-37.35M
as of Jun 30, 2026
Operating margin
-47.0%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RCEL (Nasdaq), AVHHL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Valencia, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1762303
- Former names
- Avita Therapeutics, Inc. (until Dec 10, 2020); Avita Medical, Ltd. (until Jun 30, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $70.9M | $63.9M | $50.1M | $34.4M | $29.2M |
| Operating income | -$42.5M | -$56.6M | -$42.7M | -$27.5M | -$26.5M |
| Net income | -$48.6M | -$61.8M | -$35.4M | -$26.7M | -$26.6M |
| Diluted EPS | -$1.74 | -$2.39 | -$1.40 | $1.07 | $1.17 |
| Operating cash flow | -$31.2M | -$48.9M | -$38.0M | -$19.1M | -$25.9M |
| Free cash flow | -$32.2M | -$58.1M | -$39.4M | -$19.5M | -$26.8M |
| Total assets | $56.4M | $79.7M | $111.6M | $98.3M | $125.5M |
| Total liabilities | $73.0M | $75.0M | $61.9M | $13.0M | $9.8M |
| Stockholders' equity | -$16.6M | $4.5M | $49.1M | $84.7M | $115.7M |
| Cash and investments | $18.2M | $35.9M | $89.1M | $86.3M | $110.7M |
| Total debt | $46.0M | $46.0M | $42.4M | $918,000 | $1.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 11, 2026 | Aug 5, 2026 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 6, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 8, 2026 | Jun 5, 2026 |
All 376 AVITA Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.